These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22926743)

  • 1. Patient preferences and willingness to pay for different options of anticoagulant therapy.
    Moia M; Mantovani LG; Carpenedo M; Scalone L; Monzini MS; Cesana G; Mannucci PM
    Intern Emerg Med; 2013 Apr; 8(3):237-43. PubMed ID: 22926743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of attributes and willingness to pay for oral anticoagulant therapy in patients with atrial fibrillation in China: A discrete choice experiment.
    Zhao J; Wang H; Li X; Hu Y; Yan VKC; Wong CKH; Guo Y; Cheung MKH; Lip GYH; Siu CW; Tse HF; Chan EW
    PLoS Med; 2021 Aug; 18(8):e1003730. PubMed ID: 34437553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valuing injection frequency and other attributes of type 2 diabetes treatments in Australia: a discrete choice experiment.
    Fifer S; Rose J; Hamrosi KK; Swain D
    BMC Health Serv Res; 2018 Aug; 18(1):675. PubMed ID: 30165844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Country-based Comparison of Atrial Fibrillation Patients' Preferences for Oral Anticoagulation: An Evaluation of Discrete Choice Experiments in Five Different Countries.
    Henry M; Wosnitza M; Thate-Waschke IM; Bauersachs R; Ueng KC; Chang KC; Wilke T
    J Cardiovasc Pharmacol; 2021 Jan; 77(1):100-106. PubMed ID: 33165142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient preferences for osteoporosis in Spain: a discrete choice experiment.
    Darbà J; Restovic G; Kaskens L; Balbona MA; Carbonell A; Cavero P; Jordana M; Prieto C; Molina A; Padró I
    Osteoporos Int; 2011 Jun; 22(6):1947-54. PubMed ID: 20838770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preferences for oral anticoagulant treatment in the medium and long term prevention of stroke in non valvular atrial fibrillation].
    González-Rojas N; Giménez E; Fernández MÁ; Heineger AI; Martínez JL; Villar J; Lizán L
    Rev Neurol; 2012 Jul; 55(1):11-9. PubMed ID: 22718404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment.
    Mansfield C; Gebben DJ; Sutphin J; Tepper SJ; Schwedt TJ; Sapra S; Shah N
    Headache; 2019 May; 59(5):715-726. PubMed ID: 30861110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis.
    Weernink MGM; Vaanholt MCW; Groothuis-Oudshoorn CGM; von Birgelen C; IJzerman MJ; van Til JA
    Am J Cardiovasc Drugs; 2018 Dec; 18(6):493-502. PubMed ID: 30132140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in Preferences for Anti-coagulant Use in Atrial Fibrillation: A Latent Class Analysis.
    van Til J; Oudshoorn-Groothuis C; Weernink M; von Birgelen C
    Patient; 2020 Aug; 13(4):445-455. PubMed ID: 32329020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients' preferences in anticoagulant therapy: discrete choice experiment.
    Najafzadeh M; Gagne JJ; Choudhry NK; Polinski JM; Avorn J; Schneeweiss SS
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):912-9. PubMed ID: 25387782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient Preferences for Oral Anticoagulation Therapy in Atrial Fibrillation: A Systematic Literature Review.
    Wilke T; Bauer S; Mueller S; Kohlmann T; Bauersachs R
    Patient; 2017 Feb; 10(1):17-37. PubMed ID: 27461276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician and Patient Preferences for Nonvalvular Atrial Fibrillation Therapies.
    Shafrin J; Bruno A; MacEwan JP; Campinha-Bacote A; Trocio J; Shah M; Tan W; Romley JA
    Value Health; 2016 Jun; 19(4):451-9. PubMed ID: 27325337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation Treatment in Cancer-Associated Venous Thromboembolism: Assessment of Patient Preferences Using a Discrete Choice Experiment (COSIMO Study).
    Picker N; Lee AY; Cohen AT; Maraveyas A; Beyer-Westendorf J; Mantovani LG; Abdelgawwad K; Fatoba S; Thate-Waschke IM; Bach M; Wilke T
    Thromb Haemost; 2021 Feb; 121(2):206-215. PubMed ID: 32877956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Societal preferences for fertility treatment in Australia: a stated preference discrete choice experiment.
    Botha W; Donnolley N; Shanahan M; Norman RJ; Chambers GM
    J Med Econ; 2019 Jan; 22(1):95-107. PubMed ID: 30431385
    [No Abstract]   [Full Text] [Related]  

  • 15. Valuing the delivery of dental care: Heterogeneity in patients' preferences and willingness-to-pay for dental care attributes.
    Sever I; Verbič M; Sever EK
    J Dent; 2018 Feb; 69():93-101. PubMed ID: 29242040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' adherence to oral anticoagulants therapy: Comparison between vitamin K antagonists and direct oral anticoagulants.
    Barcellona D; Mameli A; Cornacchini S; Perra F; Diovaldi M; Farci N; Moledda V; Marongiu F
    Int J Cardiol; 2021 Jun; 333():162-166. PubMed ID: 33705844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient preferences for first-line oral treatment for mild-to-moderate ulcerative colitis: a discrete-choice experiment.
    Hodgkins P; Swinburn P; Solomon D; Yen L; Dewilde S; Lloyd A
    Patient; 2012; 5(1):33-44. PubMed ID: 22077619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capturing Adult Patient Preferences Toward Benefits and Risks of Second-Line Antihyperglycemic Medications Used in Type 2 Diabetes: A Discrete Choice Experiment.
    Donnan JR; Johnston K; Chibrikov E; Marra CA; Aubrey-Bassler K; Najafzadeh M; Nguyen H; Gamble JM
    Can J Diabetes; 2020 Feb; 44(1):6-13. PubMed ID: 31311729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of outpatient anticoagulant treatment in patients with cerebral and peripheral arterial occlusive disease.
    Gorter JW; Oostenbrink JB; Tangelder MJ; ;
    Thromb Haemost; 2001 Jan; 85(1):52-6. PubMed ID: 11204588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferences for anticoagulation therapy in atrial fibrillation: the patients' view.
    Böttger B; Thate-Waschke IM; Bauersachs R; Kohlmann T; Wilke T
    J Thromb Thrombolysis; 2015 Nov; 40(4):406-15. PubMed ID: 26260625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.